Prof. Steven Chamuleau, MD, PhD
Is a cardiologist and professor at the University Medical Center (UMC) Utrecht (the Netherlands), specialized in cardiac regenerative therapy, valvular disease and cardiac imaging. He combines state-of-the-art cardiac care with promising experimental techniques and tries to implement new strategies and techniques in the pre-clinical as well as the clinical phase. As both a clinician and PI, Steven is well known for his translational work and vision.
Before he attended medical school at the University of Amsterdam, Chamuleau studied Econometrics and received a BSc degree in Biology. He finished medical school in Amsterdam and subsequently received his PhD degree cum laude in 2001 on intracoronary derived physiological parameters for clinical decision making at the Academic Medical Center (AMC) in Amsterdam under supervision of Prof. Jan Piek. After his PhD he started his residency at the AMC, where he also did his fellowship training in cardiology and cardiac imaging. After a year in Louisville in the lab of the renowned Prof. Bolli, focusing on cardiac stem cell treatment, he received a position as a staff cardiologist at the UMC Utrecht.
Prof. Chamuleau has published over 130 peer-reviewed papers and is an active member in the Dutch and European Society of Cardiology. He is a reviewer for many cardiac journals, such as EHJ and Circulation. Furthermore he is on the editorial board of ‘Frontiers in Heart Surgery’. At the moment he is a (co-)PI in several large international research consortia and clinical trials, primarily focused on stem cell treatment and valvular disease. He manages a large group of PhD Students, is deputy trainer since 2014, deputy head since 2015 and Professor of Cardiology since 2016.
Johan Maas, MSc, Strategic consultant
Johan obtained his degree in Medical Sciences from Groningen University and has worked at Medtronic from 2000 to 2015 in a variety of sales and marketing positions in the cardiac rhythm management division of Medtronic, and has significant hands-on experience with the introduction of CRT devices in several EU markets. Johan is currently also working as a consultant as a director Neuromodulation EMEA for the US device company Bioness Inc.
Prof. Pieter Doevendans MD PhD FESC
Is Chief of the Department of Cardiology and professor in Experimental Cardiology at the UMC Utrecht. Pieter A. Doevendans serves or has served as board member for several international and national scientific committees or editorial boards. As principal investigator for several prestigious European and Dutch grants, coordinates and executes several research projects that investigate the potency of cardiomyocyte progenitor cells as a novel clinical application in cardiac repair. Pieter A. Doevendans is currently co director of the Netherlands Heart Institute.